[8-K] Xos, Inc. Reports Material Event

Rhea-AI Filing Summary

Xos, Inc. furnished an 8-K announcing its financial position as of September 30, 2025 and results for the three and nine months ended September 30, 2025. The company provided these details via a press release furnished as Exhibit 99.1.

Under General Instruction B.2, the Item 2.02 information and Exhibit 99.1 are furnished and not deemed filed under Section 18 of the Exchange Act. Xos’s common stock trades on Nasdaq as XOS; its warrants trade as XOSWW, with every thirty warrants exercisable for one share of common stock at an exercise price of $345.00 per share.

FALSE000181949300018194932025-11-132025-11-130001819493us-gaap:CommonStockMember2025-11-132025-11-130001819493us-gaap:WarrantMember2025-11-132025-11-13

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2025

XOS, INC.

(Exact name of registrant as specified in its charter)

Delaware

001-39598

98-1550505

(State or Other Jurisdiction of Incorporation)

(Commission File Number)

(I.R.S. Employer Identification No.)

3550 Tyburn Street Los Angeles, California						90065
(Address of principal executive offices)						(Zip Code)

(818) 316-1890
(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240-13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Common Stock, $0.0001 par value per share

XOS

Nasdaq Capital Market

Warrants, every thirty warrants exercisable for one share of Common Stock at an exercise price of $345.00 per share

XOSWW

Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

On November 13, 2025, Xos, Inc. (the “Company”) issued a press release announcing its financial position as of September 30, 2025, results of operations for the three and nine months ended September 30, 2025 and other related information. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

In accordance with General Instruction B.2 of Form 8-K, the information included in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

Exhibit No.						Description
99.1						Press Release, dated November 13, 2025
104						iXBRL language is updated in the Exhibit Index

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: November 13, 2025

			XOS, INC.
			By:			/s/ Liana Pogosyan
						Liana Pogosyan
						Chief Financial Officer

FAQ

What did XOS (XOS) announce in this 8-K?

Xos furnished an Item 2.02 8-K with a press release detailing its financial position as of September 30, 2025 and Q3 2025 results, as Exhibit 99.1.

Which periods are covered by XOS’s results?

The press release covers results of operations for the three and nine months ended September 30, 2025, and financial position as of September 30, 2025.

Is the information considered filed or furnished?

The Item 2.02 information, including Exhibit 99.1, is furnished under General Instruction B.2 and is not deemed filed under Section 18 of the Exchange Act.

What exhibit contains XOS’s Q3 2025 results?

Exhibit 99.1 contains the press release with the financial information.

What are XOS’s Nasdaq symbols and warrant terms?

Common stock trades as XOS; warrants trade as XOSWW. Every thirty warrants are exercisable for one share at an exercise price of $345.00 per share.

When was the earliest event reported for this 8-K?

November 13, 2025.